<DOC>
	<DOCNO>NCT01160302</DOCNO>
	<brief_summary>There considerable evidence turmeric consumption may protective effect cancer progression . The purpose study examine short-term effect supplementation turmeric extract , Curcumin C3 Complex® , biomarkers head neck squamous cell carcinoma ( HNSCC ) .</brief_summary>
	<brief_title>Curcumin Biomarker Trial Head Neck Cancer</brief_title>
	<detailed_description>This open label , exploratory biomarker trial food substance Curcumin C3 Complex® subject newly diagnose HNSCC . Curcumin , novel safe nutritional interventional agent excite potential usage preventive/adjuvant agent , prevents tumor formation inhibit important molecular pathway show cause cancer progression , test tumor marker clinical trial . The primary objective evaluate biomarker response HNSCC patient food substance Curcumin C3 Complex® . This do compare post-intervention value baseline value . In addition , determine level curcumin metabolite tumor adjacent tissue .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>Subjects newly diagnose head neck squamous cell carcinoma oral cavity , oropharynx , hypopharynx larynx least one accessible tumor Subjects willing undergo tumor biopsy Subjects willing refrain nonsteroidal antiinflammatory drug ( NSAIDS ) Eastern Cooperative Oncology Group ( ECOG ) status 03 Absolute Neutrophil Count ≥ 1500/mm³ , Hgb ≥ 10g/dl Platelet count ≥ 150,000 mm3 Adequate Renal Function : serum creatinine ≤ 1.5 × upper limit normal ( ULN ) . Adequate hepatic function : total bilirubin ≤ 1.5 × ULN , aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) ≤ 2.0 × ULN Signed date institutional review board approve informed consent form protocol specific procedure perform Willingness subject surgically sterile postmenopausal use reliable method birth control duration study 2 week last dose study drug No consumption curcuminrich food subject 's knowledge within previous 48 hour Age ≥ 18 year ≤ 90 year Subjects receive anticoagulation therapy Known hypersensitivity curry black pepper Prior cancer therapy last 30 day Concurrent chemotherapy radiation Severely immunocompromised subject Subjects known HIV positive major illness , investigator 's judgment , substantially increase risk asociated subject 's participation study Pregnant nursing woman Unwillingness inability comply require study visit procedure protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>cancer</keyword>
</DOC>